FORWARD FEATURES CALENDAR

Deals

EMQ closes USD20m Series B funding round

EMQ, an Asian financial settlement network, has issued USD20 million of Series B Preferred Shares, led by WI Harper Group, with participation from new and existing investors including Abu Dhabi Capital, AppWorks, DG Ventures, Hard Yaka, Intudo Ventures, January Capital, Quest Venture Partners, SparkLabs Taipei, Vectr Fintech Partners, and VS

Spotta’s smart pest systems attracts USD1.18m in seed funding

Investors have rewarded the commercial success of Spotta’s smart pest systems with a USD1.18 million seed funding round. This investment reflects Spotta’s huge potential in global markets in farming, forestry, hospitality, and other sectors to solve the GBP320 billion (USD400 billion) problem of insect pests while dramatically reducing pesticide use.  

Biotech

Advent France Biotechnology and Invivo back Arthex Biotech

Advent France Biotechnology and Invivo Ventures have invested EUR4.25 million into Valencia-based Arthex Biotech, a pre-clinical stage life sciences company focused on the development of next generation antisense RNA therapies. The latest round follows on from an initial seed round of EUR2.7 million by Invivo and CDTI-Innvierte in December 2019,

EV Private Equity invests in e-learning company Trainor

Trainor, a provider of electrical safety training, digital solutions and consultancy services to the global energy, renewables, power and grid, and maritime industries, has secured new investment from EV Private Equity to support its ambitious international expansion plans. The investment will see EV Private Equity become the majority shareholder, alongside Trainor

New digital deal making platform looking to plug the SME gap

New digital deal platform dubbed Maksab has officially launched with the aim of helping corporate advisers and consultants serve and assist SMEs with streamlined deal-making through exclusive emerging transactions and efficient management features. Maksab connects advisors and private professional investors with SMEs that are seeking growth capital in a virtual environment.

Fund+ leads EUR38, series B financing in Indigo Diabetes

Fund+, an investment firm focused on European Life Sciences companies, has led a EUR38 million Series B financing in new portfolio company, Indigo Diabetes (Indigo). Indigo is developing a novel ‘invisible’ continuous glucose monitoring device for diabetics. Jan Van den Bossche, Partner at Fund+, will join the Board.   Indigo has

Fortunis Capital to make GB15m phased investment in Sportside

Sportstech specialist Sportside has secured backing to the value of GBP15million from impact investor Fortunis Capital Group.The ‘connect and play’ social app, scheduled to be launched in autumn, is a one-stop platform that lets people find their perfect sporting match, by age, ability or geography – and gives clubs and

Events

12 November, 2026 – 5:00 pm

Directory Listings